First Light Acquisition Group, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net income was USD 3.53 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | -0.57% |
|
+19.60% | -88.08% |
07-08 | Calidi Biotherapeutics, Inc. Enters into A Certain Loan Agreement with Dennis R. Conklin | CI |
07-05 | Calidi Biotherapeutics to Implement 1-For-10 Reverse Stock Split | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.08% | 11.23M | |
+21.23% | 127B | |
+23.50% | 117B | |
+26.29% | 27.67B | |
-20.19% | 20.33B | |
-15.96% | 16.79B | |
-17.92% | 15.63B | |
+13.35% | 14.84B | |
-47.70% | 14.65B | |
+58.94% | 14.43B |
- Stock Market
- Equities
- CLDI Stock
- News CALI BIOTPAR
- First Light Acquisition Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022